Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 1999 Aug;107(8):687-9.
doi: 10.1289/ehp.107-1566498.

Arsenic-related Bowen's disease, palmar keratosis, and skin cancer

Affiliations
Case Reports

Arsenic-related Bowen's disease, palmar keratosis, and skin cancer

M Cöl et al. Environ Health Perspect. 1999 Aug.

Abstract

Chronic arsenical intoxication can still be found in environmental and industrial settings. Symptoms of chronic arsenic intoxication include general pigmentation or focal "raindrop" pigmentation of the skin and the appearance of hyperkeratosis of the palms of the hands and soles of the feet. In addition to arsenic-related skin diseases including keratosis, Bowen's disease, basal-cell-carcinoma, and squamous-cell carcinoma, there is also an increased risk of some internal malignancies. Arsenic-related diseases are common in areas of the world where the drinking water has a high arsenic content. In this paper, we describe a 35-year-old male patient who had arsenic-related keratosis, squamous-cell carcinoma in the palmar area of his left hand, and Bowen's disease on his left thigh. The patient worked in a borax mine for 15 years, so he was exposed to arsenic in drinking water, airborne arsenic in his workplace, and had direct contact. The patient was treated for 11 months for arsenic-related keratosis until an axillary lymph node metastasis occurred; the lesion was excised and diagnosed to be malignant. Bowen's disease was detected when the patient was being treated for cancer. No other malignancy was found. The patient is still receiving regular follow-up care.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Br J Ind Med. 1982 Feb;39(1):76-81 - PubMed
    1. Br J Dermatol. 1970 Apr;82(4):361-3 - PubMed
    1. JAMA. 1987 Jan 23-30;257(4):516-8 - PubMed
    1. Br J Ind Med. 1987 Mar;44(3):196-200 - PubMed
    1. Med J Malaysia. 1993 Mar;48(1):86-92 - PubMed